Baidu
map

BMJ:垂体瘤卒中——案例报道

2016-02-18 Mechront 译 MedSci原创

患者男,85岁,因“头痛、呕吐、双眼进行性视力丧失5天”就诊。否认体重下降、惊厥、肢体或面部不适等。有高血压、腹主动脉瘤、甲状腺功能减退和良性前列腺肥大。血压110/75 mm Hg,心律齐 80次/分,格拉斯哥昏迷评分 (GCS) 15。周围神经系统检查未见明显异常。颅神经检查提示双颞侧偏盲,眼底检查未见明显异常。钠 126 mmol/L(参考范围135-145),钾 3.6 mmol/L (3

患者男,85岁,因“头痛、呕吐、双眼进行性视力丧失5天”就诊。

否认体重下降、惊厥、肢体或面部不适等。有高血压、腹主动脉瘤、甲状腺功能减退和良性前列腺肥大。

血压110/75 mm Hg,心律齐 80次/分,格拉斯哥昏迷评分 (GCS) 15。周围神经系统检查未见明显异常。颅神经检查提示双颞侧偏盲,眼底检查未见明显异常。

钠 126 mmol/L(参考范围135-145),钾 3.6 mmol/L (3.5-5),尿素 5.6 mmol/L (2.5-6.7),肌酐 101 µmol/L (70-150),C反应蛋白(CRP) 66 mg/L (<10)。全血细胞计数和肝功能是正常的。

CT:垂体窝有个肿块。MRI:鞍区肿块压迫视交叉,信号变化提示肿块内出血。如下图:


患者表现为双颞侧偏盲,需要考虑的诊断有:垂体腺瘤、垂体卒中、颅咽管瘤、脑膜瘤、胶质瘤、颅内动脉瘤。

结合患者临床表现和辅助检查,垂体瘤卒中的可能性最大。垂体瘤卒中指预先存在的垂体肿瘤发生出血或梗塞,垂体腺瘤发生卒中的风险为2-7%。垂体腺瘤比微腺瘤患者发生卒中的风险更大。

脑垂体位于刚性壁内,快速增长导致鞍内压力增高,以致于出现一系列临床表现:头痛(可以伴有恶心、呕吐);正常血管受压,导致垂体功能低下,垂体前叶促肾上腺皮质激素分泌受损,进而导致皮质醇不足;视交叉受压,导致视野缺损和视力下降;海绵窦内结构受压,导致颅神经麻痹。

垂体卒中患者出现日益恶化的体重或GCS减小,均是外科急诊切除肿瘤的指征;病情稳定的患者可以选择保守治疗,但如果不改善,可能需要进行手术治疗。

所有垂体卒中患者应该在首次发病后的4-8周进行随访;每年要去内分泌科随访;发病后3-6个月进行头颅MRI检查,此后每年行一次头颅MRI检查连续5年,然后每2年进行一次头颅MRI检查。

本例中的患者成功的接受了内镜下经蝶切除垂体瘤,激素水平恢复到正常,右眼视力得到改善,但是左眼视力恢复差。

原始出处:

Ramdeep Bajwa, Paven Preet Kaur, Headaches and hormones: a potentially lethal combination.BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.h6752

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847911, encodeId=07d7184e9113c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat May 14 22:42:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72064, encodeId=8067e2064eb, content=还是少见, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Mar 20 23:07:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67627, encodeId=ff0f6e62741, content=最终还是靠MRI, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16301696803, createdName=1de6ff0am23(暂无匿称), createdTime=Sun Mar 06 21:01:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66937, encodeId=81746693e4b, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51621695073, createdName=勇敢的医生, createdTime=Thu Mar 03 00:10:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340974, encodeId=c5be13409e44b, content=<a href='/topic/show?id=871941512a3' target=_blank style='color:#2F92EE;'>#垂体瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41512, encryptionId=871941512a3, topicName=垂体瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e62500168, createdName=ms1774076774505970, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458238, encodeId=420414582387f, content=<a href='/topic/show?id=beff41500cf' target=_blank style='color:#2F92EE;'>#垂体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41500, encryptionId=beff41500cf, topicName=垂体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f1a6007916, createdName=chendoc244, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=)]
    2016-05-14 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847911, encodeId=07d7184e9113c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat May 14 22:42:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72064, encodeId=8067e2064eb, content=还是少见, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Mar 20 23:07:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67627, encodeId=ff0f6e62741, content=最终还是靠MRI, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16301696803, createdName=1de6ff0am23(暂无匿称), createdTime=Sun Mar 06 21:01:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66937, encodeId=81746693e4b, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51621695073, createdName=勇敢的医生, createdTime=Thu Mar 03 00:10:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340974, encodeId=c5be13409e44b, content=<a href='/topic/show?id=871941512a3' target=_blank style='color:#2F92EE;'>#垂体瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41512, encryptionId=871941512a3, topicName=垂体瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e62500168, createdName=ms1774076774505970, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458238, encodeId=420414582387f, content=<a href='/topic/show?id=beff41500cf' target=_blank style='color:#2F92EE;'>#垂体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41500, encryptionId=beff41500cf, topicName=垂体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f1a6007916, createdName=chendoc244, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=)]
    2016-03-20 milkshark

    还是少见

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1847911, encodeId=07d7184e9113c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat May 14 22:42:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72064, encodeId=8067e2064eb, content=还是少见, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Mar 20 23:07:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67627, encodeId=ff0f6e62741, content=最终还是靠MRI, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16301696803, createdName=1de6ff0am23(暂无匿称), createdTime=Sun Mar 06 21:01:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66937, encodeId=81746693e4b, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51621695073, createdName=勇敢的医生, createdTime=Thu Mar 03 00:10:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340974, encodeId=c5be13409e44b, content=<a href='/topic/show?id=871941512a3' target=_blank style='color:#2F92EE;'>#垂体瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41512, encryptionId=871941512a3, topicName=垂体瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e62500168, createdName=ms1774076774505970, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458238, encodeId=420414582387f, content=<a href='/topic/show?id=beff41500cf' target=_blank style='color:#2F92EE;'>#垂体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41500, encryptionId=beff41500cf, topicName=垂体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f1a6007916, createdName=chendoc244, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=)]
    2016-03-06 1de6ff0am23(暂无匿称)

    最终还是靠MRI

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1847911, encodeId=07d7184e9113c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat May 14 22:42:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72064, encodeId=8067e2064eb, content=还是少见, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Mar 20 23:07:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67627, encodeId=ff0f6e62741, content=最终还是靠MRI, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16301696803, createdName=1de6ff0am23(暂无匿称), createdTime=Sun Mar 06 21:01:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66937, encodeId=81746693e4b, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51621695073, createdName=勇敢的医生, createdTime=Thu Mar 03 00:10:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340974, encodeId=c5be13409e44b, content=<a href='/topic/show?id=871941512a3' target=_blank style='color:#2F92EE;'>#垂体瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41512, encryptionId=871941512a3, topicName=垂体瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e62500168, createdName=ms1774076774505970, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458238, encodeId=420414582387f, content=<a href='/topic/show?id=beff41500cf' target=_blank style='color:#2F92EE;'>#垂体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41500, encryptionId=beff41500cf, topicName=垂体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f1a6007916, createdName=chendoc244, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=)]
    2016-03-03 勇敢的医生

    不错的文章

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1847911, encodeId=07d7184e9113c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat May 14 22:42:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72064, encodeId=8067e2064eb, content=还是少见, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Mar 20 23:07:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67627, encodeId=ff0f6e62741, content=最终还是靠MRI, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16301696803, createdName=1de6ff0am23(暂无匿称), createdTime=Sun Mar 06 21:01:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66937, encodeId=81746693e4b, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51621695073, createdName=勇敢的医生, createdTime=Thu Mar 03 00:10:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340974, encodeId=c5be13409e44b, content=<a href='/topic/show?id=871941512a3' target=_blank style='color:#2F92EE;'>#垂体瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41512, encryptionId=871941512a3, topicName=垂体瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e62500168, createdName=ms1774076774505970, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458238, encodeId=420414582387f, content=<a href='/topic/show?id=beff41500cf' target=_blank style='color:#2F92EE;'>#垂体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41500, encryptionId=beff41500cf, topicName=垂体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f1a6007916, createdName=chendoc244, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1847911, encodeId=07d7184e9113c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat May 14 22:42:00 CST 2016, time=2016-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72064, encodeId=8067e2064eb, content=还是少见, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Mar 20 23:07:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67627, encodeId=ff0f6e62741, content=最终还是靠MRI, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16301696803, createdName=1de6ff0am23(暂无匿称), createdTime=Sun Mar 06 21:01:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66937, encodeId=81746693e4b, content=不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51621695073, createdName=勇敢的医生, createdTime=Thu Mar 03 00:10:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340974, encodeId=c5be13409e44b, content=<a href='/topic/show?id=871941512a3' target=_blank style='color:#2F92EE;'>#垂体瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41512, encryptionId=871941512a3, topicName=垂体瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e62500168, createdName=ms1774076774505970, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458238, encodeId=420414582387f, content=<a href='/topic/show?id=beff41500cf' target=_blank style='color:#2F92EE;'>#垂体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41500, encryptionId=beff41500cf, topicName=垂体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f1a6007916, createdName=chendoc244, createdTime=Sat Feb 20 11:42:00 CST 2016, time=2016-02-20, status=1, ipAttribution=)]
    2016-02-20 chendoc244

相关资讯

Headache:疼痛恐惧在头痛中的作用

背景:反复头痛的患者通常有疼痛恐惧,疼痛恐惧可以干扰患者正常的思维进程,影响日常生活以及逃避现实、相关的负性强化导致的头痛相关残疾。目的:研究的目标主要是1.头痛患者和非头痛对照组之间疼痛恐惧(FOP)的差异2.根据原发性头痛诊断组的诊断区分FOP的差异3.评估FOP可预测头痛变量(严重程度,频率,致残率)的程度4.评估FOP是否能影响疼痛严重性跟头痛相关残疾之间的关系。方法:908名年轻成人(平

透视镜辅助麻醉可治头痛

透视镜辅助进行三叉神经部位局麻注射目前被用于治疗偏头痛与其他类型的头同类疾病。一项新的研究发现:在透视镜的辅助下对蝶腭神经节(SPG)进行麻醉能够提高1/3的头疼的治疗效果。美国Albany医学中心介入放射学的首席研究员Kenneth Mandato博士说到。透视成像法介导的SPG阻断"能够消除慢性头痛带来的痛苦与障碍,有可能发展成为传统治疗手段的一项补充疗法",研究员总结道。该项研究在美国年度介

JAMA Neurol:警惕以“短暂性脑缺血发作”为症状的“脑出血”

脑出血(ICH)患者可能会出现短暂性脑缺血发作(TIA)类似症状。缺乏脑部影像学检查时,小的脑出血所表现出的症状与TIA很难区分开来。该类患者应进行影像学检查,在CT或MRI排除脑出血之前,不应该进行抗血栓药物的治疗。通常情况下ICH患者随着事件推移会出现神经功能缺损。恶心、呕吐、意识障碍和显著的高血压是常见的表现特征。不过最近的一名左侧颞叶出血表现出短暂的语言障碍,症状疑是TIA。研究者对213

EUR J NEUROL:滥用药物导致头痛怎么办?(BIMOH研究)

挪威奥斯陆大学健康和社会学研究所全科医学教授Kristoffersen E S和同事研究初级医疗机构中MOH(Medication-overuse headache,药物滥用引起的头痛)患者的能力丧失、焦虑和抑郁情况(BIMOH研究),发现在初级医疗机构中通过日常事务干预治疗MOH是有效的。研究结果在线发表于European Journal of Neurology。

Baidu
map
Baidu
map
Baidu
map